Insider Transactions in Q2 2021 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 09
2021
|
Ronit Satchi Fainaro |
BUY
Acquisition or disposition by will or laws
|
Direct |
550
+1.47%
|
-
|
Jun 09
2021
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,565
+6.63%
|
-
|
Jun 09
2021
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+19.52%
|
-
|
Jun 09
2021
|
Amir Elstein |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+0.62%
|
-
|
Jun 09
2021
|
Jean Michel Halfon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+20.47%
|
-
|
Jun 09
2021
|
Gerald M Lieberman |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+18.82%
|
-
|
Jun 09
2021
|
Roberto Mignone |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+22.24%
|
-
|
Jun 09
2021
|
Perry Nisen |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+22.24%
|
-
|
Jun 09
2021
|
Ronit Satchi Fainaro |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+25.85%
|
-
|
Jun 09
2021
|
Janet S. Vergis |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+50.0%
|
-
|
Jun 09
2021
|
Nechemia Jacob Peres Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,668
+22.24%
|
-
|
Jun 05
2021
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,565
+5.62%
|
-
|
Jun 05
2021
|
Amir Elstein |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+0.3%
|
-
|
Jun 05
2021
|
Jean Michel Halfon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+14.18%
|
-
|
Jun 05
2021
|
Gerald M Lieberman |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+12.59%
|
-
|
Jun 05
2021
|
Roberto Mignone |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+16.04%
|
-
|
Jun 05
2021
|
Perry Nisen |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+16.04%
|
-
|
Jun 05
2021
|
Nechemia Jacob Peres Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+16.04%
|
-
|
Jun 05
2021
|
Ronit Satchi Fainaro |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+20.34%
|
-
|
Jun 05
2021
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
6,041
+13.25%
|
-
|
May 21
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
40,000
-54.7%
|
$440,000
$11.01 P/Share
|
May 11
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
19,804
-21.31%
|
$198,040
$10.22 P/Share
|
May 11
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
37,884
+28.96%
|
-
|
May 11
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
19,066
-17.12%
|
$190,660
$10.22 P/Share
|
May 11
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
37,884
+25.39%
|
-
|
May 11
2021
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
37,884
+39.31%
|
-
|
May 11
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
37,884
-92.72%
|
$378,840
$10.22 P/Share
|
May 11
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,884
+48.11%
|
-
|